Original Articles
Visualizações

Arq. Bras. Oftalmol. 2021; 84 (3): 10.5935/0004-2749.20210036

Total: 2671

Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results

Elif Ertan1; Mustafa Doğan2; Onur Polat3; Neriman Efe2; Müberra Akdoğan2; Sibel İnan2; ReşatDuman4; Rahmi Duman5

DOI: 10.5935/0004-2749.20210036

1. Department of Ophthalmology, Gaziosmanpaşa Training and Research Hospital, İstanbul, Turkey
2. Department of Ophthalmology, School of Medicine, Afyonkarahisar University of Health Sciences, Afyonkarahisar, Turkey
3. Department of Ophthalmology, Bursa Dünya Göz Hospital, Bursa Turkey
4. Department of Ophthalmology, Bursa City Hospital, Bursa, Turkey
5. Department of Ophthalmology, Liv Hospital, Ankara, Turkey

Corresponding author

Elif Ertan
E-mail: [email protected]

Funding: This study received no specific financial support.

Disclosure of potential conflicts of interest: None of the authors have any potential conflicts of interest to disclose.


Print PDF English
Open Access
Share

How to cite this article:

Ertan E, Doğan M, Polat O, Efe N, Akdoğan M, İnan S, et al. Mudança de tratamento para o aflibercepte no tratamento da Degeneração Macular neovascular Relacionada à Idade: resultados de 30 meses. Arq. Bras. Oftalmol. 2021;84(3):. 10.5935/0004-2749.20210036
Export citation